IDI [Cogint] 8-K: Execution Version SEPARATION AND DISTRIBUTION AGREEMENT by and

[Execution Version SEPARATION AND DISTRIBUTION AGREEMENT by and among COGINT, INC. and RED VIOLET, INC. Dated as of February 27, 2018 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 1 ARTICLE II THE INTERNAL REORGANIZATION 8 Section 2.1 Internal Reorganization 8 Section 2.2 Consents 8 Section 2.3 Termin]

By | 2018-03-04T17:43:46+00:00 February 28th, 2018|Categories: Chinese Stocks, IDI, Webplus ver|Tags: , , , , , |0 Comments

PTR [PETROCHINA CO] 6-K: (Original Filing)

[PETROCHINA COMPANY LIMITED (a joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 857) NOTICE OF BOARD MEETING Board Company PRC The board of directors (the “ By order of the Board PetroChina Company Limited Secretary to the Board Wu Enlai ]

By | 2018-03-04T18:18:18+00:00 February 28th, 2018|Categories: Chinese Stocks, PTR, SEC Original|Tags: , , , , , |0 Comments

PTR [PETROCHINA CO] 6-K: PETROCHINA COMPANY LIMITED (a joint stock limited company

[PETROCHINA COMPANY LIMITED (a joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 857) NOTICE OF BOARD MEETING Board Company PRC The board of directors (the “ By order of the Board PetroChina Company Limited Secretary to the Board Wu Enlai ]

By | 2018-03-04T18:18:22+00:00 February 28th, 2018|Categories: Chinese Stocks, PTR, Webplus ver|Tags: , , , , , |0 Comments

SOHU [SOHU COM] 10-K: (Original Filing)

[Table of Contents PAGE PART I Item 1 Business 2 Item 1A Risk Factors 47 Item 1B Unresolved Staff Comments 105 Item 2 Properties 105 Item 3 Legal Proceedings 106 Item 4 Mine Safety Disclosures 106 PART II Item 5 106 Item 6 Selected Financial Data 108 Item 7 Management’s Discussion and Analysis of Fin]

CYOU [Changyou.com] 20-F: (Original Filing)

[INTRODUCTION 1 PART I 2 Item 1. Identity of Directors, Senior Management and Advisers 2 Item 2. Offer Statistics and Expected Timetable 2 Item 3. Key Information 2 Item 4. Information on the Company 46 Item 4A. Unresolved Staff Comments 73 Item 5. Operating and Financial Review and Prospects 73 Item]

By | 2018-02-28T14:01:26+00:00 February 28th, 2018|Categories: Chinese Stocks, CYOU, SEC Original|Tags: , , , , , |0 Comments

SOHU [SOHU COM] 10-K: Table of Contents PAGE PART I Item 1

[Table of Contents PAGE PART I Item 1 Business 2 Item 1A Risk Factors 47 Item 1B Unresolved Staff Comments 105 Item 2 Properties 105 Item 3 Legal Proceedings 106 Item 4 Mine Safety Disclosures 106 PART II Item 5 106 Item 6 Selected Financial Data 108 Item 7 Management’s Discussion and Analysis of Fin]

CYOU [Changyou.com] 20-F: INTRODUCTION 1 PART I 2 Item 1. Identity

[INTRODUCTION 1 PART I 2 Item 1. Identity of Directors, Senior Management and Advisers 2 Item 2. Offer Statistics and Expected Timetable 2 Item 3. Key Information 2 Item 4. Information on the Company 46 Item 4A. Unresolved Staff Comments 73 Item 5. Operating and Financial Review and Prospects 73 Item]

By | 2018-02-28T14:01:31+00:00 February 28th, 2018|Categories: Chinese Stocks, CYOU, Webplus ver|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 6-K: (Original Filing)

[FOR RELEASE February 28, 2018 China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2017 --4Q17 Total Sales Up 12.2% YoY and Non-GAAP Adjusted Net Income Down 6.8% YoY in RMB terms, or Total Sales Up 16.1% YoY to $90.1 Million and Net Income Down 226.8% YoY to a net loss of]

NQ [NQ Mobile] 6-K: (Original Filing)

[Link Motion Announces Extraordinary General Meeting Results Link Motion Company BEIJING, Feb. 27, 2018 /PRNewswire/ -- Link Motion Inc., formerly known as NQ Mobile Inc., (NYSE: NQ) (" At the meeting, the shareholders of Link Motion approved the following resolution: 1. RESOLVED, as a special resolu]

By | 2018-02-28T14:02:14+00:00 February 28th, 2018|Categories: Chinese Stocks, NQ, SEC Original|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 6-K: FOR RELEASE February 28, 2018 China Biologic Reports

[FOR RELEASE February 28, 2018 China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2017 --4Q17 Total Sales Up 12.2% YoY and Non-GAAP Adjusted Net Income Down 6.8% YoY in RMB terms, or Total Sales Up 16.1% YoY to $90.1 Million and Net Income Down 226.8% YoY to a net loss of]

By | 2018-03-04T19:34:13+00:00 February 28th, 2018|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar